Chapter 178 Lin Feng’s Two Super Moves

So in terms of the number of patients, the number of hepatitis B patients is naturally much greater than that of AIDS patients.

If Lin Feng can develop a gene therapy drug specifically for the hepatitis B virus, it will definitely make foreign countries sit up and take notice.

Because although there is already a specific drug for hepatitis B on the market, the price of this drug is too outrageous.

That’s why the 2018 film “Dying to Survive” became such a huge hit.

It is indeed a true story that has aroused the empathy and recognition of the majority of netizens.

As for the real price of Xia Fanning?
The price of the Daxia version is 21660 yuan per bottle, and one bottle can be used for one month.

Generally, it takes three months of continuous taking to eliminate the hepatitis B virus in the body and turn positive into negative.

What if it’s not cured after three months?
Then you have to continue taking it until the day you are cured.

What if you don’t have money to continue treatment?
Then that's your business, not Gilead's.

For Gilead, it’s up to you whether you want to buy it or not, and whether you want your life or money.

This means that if a hepatitis B patient wants to treat hepatitis B, he or she will need to pay at least 6.4 yuan!

And the 6.4 yuan does not include the cost of going to the hospital for examination, nor does it include the travel expenses!

If hepatitis B is not cured after a three-month course of treatment, you will have to pay 21660 yuan every month to suppress the deterioration of the disease, which will eventually make you bankrupt!

It can be said that if you want to treat hepatitis B, you must be prepared to make drastic changes and to endure great pains. If you don’t have any savings, then you can just wait for death.

Under such circumstances, the expensive cost of hepatitis B treatment leaves Lin Feng with room to perform.

After all, compared to Xia Fanning's treatment, which takes at least three months to see results, genetic medical drugs using gene editing technology can cure the disease in at most a week.

Just like the AIDS-specific drug 'EBT-002 Gene Therapy Drug', it only takes one week to go from positive to negative.

Of course, in terms of cost, Xingtu Technology is actually not as good as Gilead, because the price of Indu’s infringing and pirated drugs is 28 yuan!

But of course, Gilead cannot really lower the price to such an extent. If they do so, what will they eat and drink?

Therefore, the hepatitis B gene medical drug launched by Xingtu Technology will not cause sudden death, but can help people survive.

If you want to complete the treatment quickly within a week, you can choose Xingtu Technology’s hepatitis B gene medical drug.

If you want to gamble on the success rate of drug treatment in three months, you can choose Xia Fanning, which has a lower production cost and a lower selling price.

During this period, Lin Feng can also take the opportunity to make a lot of money and provide more scientific research funds to Xingtu Gene Company.

After all, one bottle of Xia Fanning costs 21660 yuan, and a course of treatment of three bottles over three months would cost at least 6.4 yuan.

Lin Feng's hepatitis B gene medical drugs only cost them 30,000 to 40,000 yuan. That's not expensive, right?
And you can also use medical insurance, and in the end you only need to pay a few percent of the price with medical insurance reimbursement.

And the best part is that it only takes a week to quickly resolve that damn hepatitis B virus.

I believe that with the emergence of such hepatitis B gene medical drugs, the treatment cost will be half as cheap.

This will definitely make foreign countries sit up and take expedited approval of clinical trials and marketing of hepatitis B gene medical drugs.

What should we do if the hepatitis B gene medical drug doesn’t work?
If that still doesn’t work, Lin Feng will have to use his ultimate move, which is the genetic medical drug for diabetes!
In 2015, there were 4.15 million diabetes patients. When a specific drug for diabetes came out, Lin Feng didn't believe that overseas medical authorities would be able to sit still.

Even if they can still sit still by then, those hepatitis B and diabetes patients will dare to block their doors.

So this is Lin Feng’s final decision.

Of course, Lin Feng still doesn't want to solve the diabetes problem first. Because in order to treat diabetes, genes must be modified. Although Lin Feng has mastered the technology of second-generation and third-generation gene enhancement drugs and 'EBT-002 gene medical drugs', he is the world's first person in the field of gene editing.

But every human disease has its own characteristics and cannot be simply applied. It requires specific treatment.

Therefore, although Lin Feng is confident that he can develop genetic medical drugs for diabetes with his knowledge and smart brain.

But to achieve this would definitely take a lot of time, and what Lin Feng lacks most is time.

So Lin Feng chose to solve the hepatitis B problem which is simpler and easier to produce results.

Because the hepatitis B gene medical drug that Lin Feng is preparing to develop will not modify human genes, it still targets the hepatitis B virus in the human body, so the results will naturally be produced more quickly.

After all, destruction is always easier than construction. The most difficult technical problem is how to avoid stimulating the immune response of the human body and cells, and this is what the 'RNP complex' has achieved.

It can overcome numerous blockades by the immune system and cells, and ultimately reach directly into the cell nucleus to modify human genes.

Among these, Lin Feng only needed to make certain modifications to the 'RNP complex' and delete the function of modifying the gene.

It only retains the function of identifying the hepatitis B virus gene fragment, and then cutting off the hepatitis B virus gene fragment, rendering the hepatitis B virus inactivated and dead.

It is difficult for others to do this, but it is very easy for Lin Feng who has mastered the knowledge of manufacturing gene enhancement drugs and 'EBT-002 gene medical drugs'.

This is like asking an academician of Daxia to answer a high school math problem.

This math problem is difficult for high school students, but it is not difficult at all for Academician Daxia.

At this time, Lin Feng was even confident that he could produce samples in a week and then conduct relevant experiments.

Thinking of this, Lin Feng knew that he had one more task to accomplish, and then he smiled bitterly.

However, thinking of the importance of Xingtu Gene Company, Lin Feng could only overcome the depression and helplessness in his heart.

After all, although he had obtained the third-generation gene enhancement drug and achieved his goal, in theory, Xingtu Gene Company seemed useless.

But in fact, the role of Xingtu Gene Company has not only not decreased, but has become more important.

Because the third-generation gene enhancement potion only gives you a strong body and brain, allowing you to possess the magical genes of 7 animals and use special abilities.

However, the third-generation gene-enhancing drugs cannot guarantee that you will stay young forever, nor can they guarantee that you will not be immune to diseases, viruses, or chemical toxins.

So Lin Feng will age and get sick just like his parents, and will die from viruses and be poisoned by chemical toxins.

Considering the wide variety of natural and man-made viruses on Earth, chemical toxins are also diverse.

Therefore, for Raymond Lam and his parents, the best way to prevent the disease is to have a large medical research and development team to support them.

Only by becoming the strongest swordsman can you forge the strongest shield to defend against the enemy's sword.

Of course, Lin Feng's decision to develop hepatitis B gene medical drugs will force foreign medical authorities to collapse.

The outside world is unaware of the final expedited approval of the clinical trials and marketing of the 'EBT-002 gene medical drug' and the 'Hepatitis B gene medical drug'.

At this time, the global media are vigorously promoting the "Bode-001 AIDS specific drug" developed by the Broad Institute.

For a while, people only knew about the 'Bode-001 AIDS specific drug' and forgot about the 'EBT-002 gene medical drug' of Xingtu Gene Company.

As a result, the number of people coming to Daxia for AIDS treatment began to decline linearly.

　There will be a recommendation on the 5th, and there will be three updates in the next three consecutive days. Please vote for recommendations and monthly tickets.

　　
　
(End of this chapter)